These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18240669

  • 1. Adverse effects of bisphosphonates: current issues.
    Diel IJ, Bergner R, Grötz KA.
    J Support Oncol; 2007; 5(10):475-82. PubMed ID: 18240669
    [Abstract] [Full Text] [Related]

  • 2. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA, López Tarruella S, García Paredes B, Rodríguez Lajusticia L, Villalobos L, Díaz Rubio E.
    Med Oral Patol Oral Cir Bucal; 2007 Sep 01; 12(5):E351-6. PubMed ID: 17767097
    [Abstract] [Full Text] [Related]

  • 3. Safety profile of intravenous bisphosphonates.
    Mehrotra B.
    Semin Oncol; 2007 Dec 01; 34(6 Suppl 4):S24-7. PubMed ID: 18068487
    [Abstract] [Full Text] [Related]

  • 4. Bisphosphonates for breast cancer.
    Pavlakis N, Schmidt R, Stockler M.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD003474. PubMed ID: 16034900
    [Abstract] [Full Text] [Related]

  • 5. Breast cancer: bisphosphonate therapy for metastatic bone disease.
    Body JJ.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6258s-6263s. PubMed ID: 17062710
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonate treatment recommendations for oncologists.
    von Moos R.
    Oncologist; 2005 Oct 15; 10 Suppl 1():19-24. PubMed ID: 16264109
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug 15; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 9. Safety considerations with bisphosphonates for the treatment of osteoporosis.
    Strampel W, Emkey R, Civitelli R.
    Drug Saf; 2007 Aug 15; 30(9):755-63. PubMed ID: 17722968
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ, Ramalingam L, Zacharin MR.
    Clin Endocrinol (Oxf); 2008 Jun 15; 68(6):863-7. PubMed ID: 18221397
    [Abstract] [Full Text] [Related]

  • 12. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
    Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM.
    Oncologist; 2008 Aug 15; 13(8):911-20. PubMed ID: 18695259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
    Diel IJ, Fogelman I, Al-Nawas B, Hoffmeister B, Migliorati C, Gligorov J, Väänänen K, Pylkkänen L, Pecherstorfer M, Aapro MS.
    Crit Rev Oncol Hematol; 2007 Dec 15; 64(3):198-207. PubMed ID: 17855108
    [Abstract] [Full Text] [Related]

  • 15. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.
    Conte P, Guarneri V.
    Oncologist; 2004 Dec 15; 9 Suppl 4():28-37. PubMed ID: 15459427
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov 15; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.